4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-25-000406
CHIEF MEDICAL OFFICER acquired 16,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luptakova Katarina CHIEF MEDICAL OFFICER | 2025-01-01 | Option exercise | +16,625 | 16,625 | D | ||
| Derivatives | |||||||
| Luptakova Katarina CHIEF MEDICAL OFFICER | 2025-01-01 | Option exercise · Restricted Stock Units | −16,625 | 49,875 | D | ||
| Luptakova Katarina CHIEF MEDICAL OFFICER | 2025-01-01 | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | D | ||
Loading xslF345X05/form4-01032025_040113.xml…